@misc{indiciaeb8a855ff9790,
  title = {Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation},
  author = {Oren, Y. S. and Irony-Tur Sinai, M. and Golec, A. and Barchad-Avitzur, O. and Mutyam, V. and Li, Y. and Hong, J. and Ozeri-Galai, E. and Hatton, A. and Reiter, J. and Sorscher, E. J. and Wilton, S. D. and Kerem, E. and Rowe, S. M. and Sermet-Gaudelus, I. and Kerem, B.},
  year = {2021},
  doi = {10.1101/2021.02.14.431123},
  url = {https://www.biorxiv.org/content/10.1101/2021.02.14.431123v1},
  note = {Source identifier: 10.1101/2021.02.14.431123}
}